Literature DB >> 22024589

IRES-mediated Tricistronic vectors for enhancing generation of high monoclonal antibody expressing CHO cell lines.

Steven C L Ho1, Muriel Bardor, Huatao Feng, Yen Wah Tong, Zhiwei Song, Miranda G S Yap, Yuansheng Yang.   

Abstract

A Tricistronic vector utilizing internal ribosome entry site (IRES) elements to express the light chain (LC), heavy chain (HC), and a neomycin phosphotransferase (NPT) selection marker from one transcript is designed for generation of mAb expressing CHO cell lines. As compared to the commonly used vectors, benefits of this design include: (1) minimized non-expressing clones, (2) enhanced stable mAb productivity without gene amplification, (3) control of LC and HC expression at defined ratios, and (4) consistent product quality. After optimization of the LC and HC arrangement and increasing selection stringency by weakening the NPT selection marker, this Tricistronic vector is able to generate stably transfected pools with specific productivity (qmAb) greater than 5pg/cell/day (pcd) and titers over 150mg/L. 5% of clones from these pools have qmAb greater than 20pcd and titers ranging from 300 to more than 500mg/L under non-optimized shake flask batch cultures using commercially available protein-free medium. The mAb produced by these clones have low aggregation and consistent glycosylation profiles. The entire process of transfection to high-expressing clones requires only 6 months. The IRES-mediated Tricistronic vector provides an attractive alternative to commonly used vectors for fast generation of mAb CHO cell lines with high productivity.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22024589     DOI: 10.1016/j.jbiotec.2011.09.023

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  38 in total

1.  Laboratory Scale Production and Purification of a Therapeutic Antibody.

Authors:  Zehra Elgundi; Vicki Sifniotis; Mouhamad Reslan; Esteban Cruz; Veysel Kayser
Journal:  J Vis Exp       Date:  2017-01-24       Impact factor: 1.355

2.  IgG Aggregation Mechanism for CHO Cell Lines Expressing Excess Heavy Chains.

Authors:  Steven C L Ho; Tianhua Wang; Zhiwei Song; Yuansheng Yang
Journal:  Mol Biotechnol       Date:  2015-07       Impact factor: 2.695

3.  Correlation Between Expression of Recombinant Proteins and Abundance of H3K4Me3 on the Enhancer of Human Cytomegalovirus Major Immediate-Early Promoter.

Authors:  Benjamin P C Soo; Julian Tay; Shirelle Ng; Steven C L Ho; Yuansheng Yang; Sheng-Hao Chao
Journal:  Mol Biotechnol       Date:  2017-08       Impact factor: 2.695

4.  Construction strategies for developing expression vectors for recombinant monoclonal antibody production in CHO cells.

Authors:  Yan-Mei Li; Zheng-Wei Tian; Dan-Hua Xu; Xiao-Yin Wang; Tian-Yun Wang
Journal:  Mol Biol Rep       Date:  2018-09-06       Impact factor: 2.316

5.  Cleavage efficient 2A peptides for high level monoclonal antibody expression in CHO cells.

Authors:  Jake Chng; Tianhua Wang; Rui Nian; Ally Lau; Kong Meng Hoi; Steven C L Ho; Peter Gagnon; Xuezhi Bi; Yuansheng Yang
Journal:  MAbs       Date:  2015       Impact factor: 5.857

Review 6.  Recent advances in mammalian protein production.

Authors:  Ashok D Bandaranayake; Steven C Almo
Journal:  FEBS Lett       Date:  2013-12-06       Impact factor: 4.124

Review 7.  Recombinant antibodies aggregation and overcoming strategies in CHO cells.

Authors:  Tingting Xu; Jihong Zhang; Tianyun Wang; Xiaoyin Wang
Journal:  Appl Microbiol Biotechnol       Date:  2022-05-24       Impact factor: 4.813

8.  Impact of using different promoters and matrix attachment regions on recombinant protein expression level and stability in stably transfected CHO cells.

Authors:  Steven C L Ho; Jessna H M Yeo; Shiyi Goh Fang; Yuansheng Yang
Journal:  Mol Biotechnol       Date:  2015-02       Impact factor: 2.695

Review 9.  Expression vector cassette engineering for recombinant therapeutic production in mammalian cell systems.

Authors:  Tian-Yun Wang; Xiao Guo
Journal:  Appl Microbiol Biotechnol       Date:  2020-05-06       Impact factor: 4.813

10.  Recombinant Antibody Production Using a Dual-Promoter Single Plasmid System.

Authors:  Stefania C Carrara; David Fiebig; Jan P Bogen; Julius Grzeschik; Björn Hock; Harald Kolmar
Journal:  Antibodies (Basel)       Date:  2021-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.